Jim Cramer On Clover Health Investments, Corp. (CLOV): 'I Just Don't Want To Go There'
Clover Health Options Spot-On: On October 17th, 98,417 Contracts Were Traded, With 350.93K Open Interest
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
Clover Health Options Spot-On: On October 16th, 65,815 Contracts Were Traded, With 331.66K Open Interest
2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors
UnitedHealth Dips as Cost Concerns Weigh on Insurance Unit
Clover Health: A Strong Buy on 4-Star Rating and Competitive Edge
Clover Health Options Spot-On: On October 11th, 73,952 Contracts Were Traded, With 318.37K Open Interest
Sector Update: Health Care Stocks Rise Late Afternoon
Why Clover Health (CLOV) Stock Is Rising
Clover Health Shares Are Trading Higher After the Centers for Medicare and Medicaid Services Increased the Star Rating of Its PPO Medicare Advantage Plans to 4 Stars for 2025.
Clover Gains, Humana Dips as Medicare Finalizes 2025 Star Ratings
Express News | Clover Health- in Payment Year 2026,Sees to Experience General 5% Quality Bonus Increase in Benchmark Rates Due to Ppo Contract Being Rated 4.0 Stars
Express News | Clover Health Ppo Medicare Advantage Plans Earn 4 Star Rating for 2025
Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025
Express News | Biden-Harris Administration Proposes Medicare $2 Drug List Model To Lower Prescription Costs; CMS Seeks Feedback On Sample Drug List And Outreach With Voluntary Participation For Part D Sponsors Starting As Early As Jan 2027; Model To Include Drugs...
Press Release: Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer
Express News | Counterpart Health Names David Tsay M.d., Ph.d as Chief Medical Officer
Clover Health Investments Price Target Announced at $4.00/Share by UBS
Clover Health Investments Analyst Ratings